MEG3 and ovarian carcinoma: In this study, we comprehensively demonstrated that lncRNA MEG3 is regulated by METTL3-mediated YTHDF2 methylation; it upregulates VASH1 through regulatory competitive binding to hsa-miR-885-5p and then inhibits ovarian cancer cell proliferation, migration, and invasion.